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The local cytokine environment and the presence of stimulatory signals determine whether monocytes acquire
dendritic cell or macrophage characteristics and functions. In this study, we examined the effect of histamine, a
prototypic mediator of allergic inﬂammation, on the granulocyte-macrophage colony-stimulating factor (GM-CSF)
and interleukin (IL)-4-driven differentiation of monocytes into monocyte-derived dendritic cells (MoDC), which
typically showed CD1aþCD14 phenotype. Monocytes from healthy adult donors were cultured with GM-CSF and
IL-4 in the presence or absence of histamine, and the phenotypes and function of these cells were analyzed.
Histamine induced the generation of CD1aCD14þ cells, which exhibited cytological and phenotypical charac-
teristics of dendritic cells (DC), showed enhanced phagocytic activity and cytokine-producing capacity, but dem-
onstrated weak allo-stimulatory capacity compared with CD1aþCD14 MoDC. The inhibitory effects of histamine
on CD1aþCD14 MoDC differentiation were antagonized by cimetidine, an H2 receptor antagonist, but not by H1
and H3 receptor blockers, and were mimicked by an H2 receptor agonist. Culture supernatant of histamine-treated
monocytes also inhibited CD1aþCD14 MoDC differentiation, which was restored by the removal of IL-10. These
results suggest that histamine-driven CD1aCD14þ DC amplify their antigen-independent inﬂammatory reaction
and may contribute to the exacerbation of allergic diseases.
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A lack of appropriate exogenous stimuli induces monocytes
to undergo apoptosis, whereas under the influence of dis-
tinct signals such as proinflammatory cytokines, these cells
differentiate into macrophages or dendritic cells (DC) (Katoh
et al, 2000; Lanzavecchia and Zallusto, 2001). Macrophages
can perform phagocytosis and produce proinflammatory or
anti-inflammatory cytokines that regulate inflammatory re-
actions (Novak et al, 2001). In contrast, DC display the ca-
pacity to initiate primary and secondary T cell responses
and the most efficient professional antigen-presenting cells
(Lanzavecchia and Zallusto, 2001). DC comprise heteroge-
neous populations with different morphologies and mole-
cules expressed as a function of their maturation stage
(Grassi et al, 1998). Dermal DC (DDC) migrated from skin
explants are divided into three subsets by phenotypic cri-
teria: CD1aCD14, CD1aþCD14, and CD1aCD14þ
(Nestle et al, 1993; Larregina et al, 2001). CD1aCD14þ
subset of DDC show decreased capacity to stimulate rest-
ing T cells when compared with the other two subsets.
These fundamental functional divergences may be of im-
portance for the putative regulatory role of monocyte-
derived DC (MoDC) or macrophages in tissues, and con-
sequently for the outcome of local inflammatory responses
(Novak et al, 1999). Thus far, several factors such as cor-
ticosteroids, interleukin (IL)-10, and signaling evoked by the
engagement of FceRI are known to influence monocyte dif-
ferentiation into DC (Buelens et al, 1997; Novak et al, 2001;
Woltman et al, 2002).
Histamine is an important mediator involved in various
physiological and pathological conditions including imme-
diate hypersensitivity reaction and inflammation (Leurs et al,
1995). Recently, new immunomodulatory functions of his-
tamine were discovered (Jutel et al, 2002) (i) histamine aug-
ments antigen-receptor-mediated T and B cell proliferation
(Banu and Watanabe, 1999), (ii) enhances Th1-type re-
sponses by triggering H1 receptor (H1R), whereas Th1- and
Th2-type responses are negatively regulated by H2R (Jutel
et al, 2001), and (iii) alters the repertoire of cytokines and
chemokines secreted by mature DC that induces the po-
larization of naı¨ve CD4þ T cells toward Th2 phenotypes
(Caron et al, 2001; Mazzoni et al, 2001). Therefore, hista-
mine may contribute to other mechanisms involved in the
outcome of DC differentiation.
In this report, we examined the effect of histamine on
the granulocyte-macrophage colony-stimulating factor (GM-
CSF) and IL-4-driven differentiation of monocytes into
MoDC. In monocytes from non-atopic healthy individuals
Abbreviations: AD, atopic dermatitis; DC, dendritic cells; DDC,
dermal dendritic cells; FITC, fluorescein isothiocyanate; GM-CSF,
granulocyte-macrophage colony-stimulating factor; HR, histamine
receptor; IFN-g, interferon-g; IL, interleukin; LC, Langerhans cells;
LPS, lipopolysaccharide; mAb, monoclonal antibody; M-CSF, ma-
crophage colony-stimulating factor; MFI, mean fluorescence in-
tensity; MoDC, monocyte-derived dendritic cells; rFI, relative
fluorescence intensity
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we found that (1) histamine prevents the generation of
CD1aþCD14 DC and induces CD1aCD14þ DC, which
share some phenotypic and functional features with previ-
ously described CD1aCD14þ DDC (Nestle et al, 1993;
Larregina et al, 2001); (2) the effect is mediated by H2R; and
(3) it results from the histamine-induced secretion of IL-10.
Results
Histamine alters GM-CSF- and IL-4-induced differentia-
tion of monocytes into DC At the start of culturing, the
cells used to generate MoDC in a typical experiment con-
sisted of 95% monocytes, as indicated by CD14 expression
and a typical light-scattering profile. They were induced to
differentiate into MoDC with IL-4 and GM-CSF over a period
of 6 d. Under control conditions with GM-CSF and IL-4, the
cells rapidly became non-adhered to culture plate and
formed large clusters. Histamine-treated cells were also
non-adhered and formed clusters. Both of them were ir-
regularly shaped and showed extended veils (Fig 1A). The
dendritic morphology with small dendrites was also ob-
served in both of them. In contrast, macrophage colony-
stimulating factor (M-CSF)-induced macrophages were ad-
herent, roundly shaped cells containing numerous vacuoles.
Despite homogeneous cytological appearance, the ex-
pression of CD1a and CD14 by DC significantly changed
when histamine was added at the start of culturing (Fig 1B).
MoDC generated with GM-CSF and IL-4 expressed high
levels of CD1a and low levels of CD14. In contrast, those
generated in the presence of histamine expressed signifi-
cantly lower levels of CD1a and higher levels of CD14. This
inhibitory effect was significant at 100 nM, and highest at
100 mM, the highest concentration tested (Fig 1C). Hista-
mine at 10 mM was used in the following experiment be-
cause it is within the concentration range of histamine
detected in nasal secretions and brochoalveolar lavages
from allergic patients after allergen challenge (Wenzel et al,
1988; Liu et al, 1990; Baroody et al, 1999). The addition of
histamine after 48 h, when most DC already expressed
CD1a, still resulted in a significant decrease in CD1a surface
expression. This downregulatory effect, however, was not
observed when histamine was added on day 3 or later (data
not shown). Histamine significantly inhibited the generation
of CD1aþ mature MoDC when 100 ng per mL of lip-
opolysaccharide (LPS) was added on day 6 in addition to
IL-4 and GM-CSF (Figs 1D and 2B).
We further examined whether histamine has any effect on
the DC phenotype at day 6 (Fig 2A). Histamine induced a
significant increase in MHC class II molecules, mannose re-
ceptor, CD11b, and CD68. On the other hand, the expres-
sions of CD40 and CD80 were downregulated. No significant
change was observed in CD86, CD83, CD1b, M-CSF recep-
tor, and FXIIIa expression. LPS-matured histamine-treated
DC demonstrated similar phenotypes with control-matured
MoDC including CD83, except CD1a and CD14 (Fig 2B).
The viability of the cells observed when comparing the
histamine-treated and untreated group using trypan blue
dye exclusion was not significantly different, suggesting that
the inhibitory effect of histamine on DC differentiation was
not because of the induction of cell death (data not shown).
Histamine alters DC function A characteristic feature of
DC is their capacity to stimulate naı¨ve T cells, as seen in the
model of allogeneic mixed lymphocyte reaction (MLR). To
determine the functional characteristics of cells generated
in the presence of histamine, we examined whether hista-
mine affects their T cell-stimulating capacity in MLR. As
shown in Fig 3, compared with MoDC generated under
control conditions, histamine-treated DC exhibited signifi-
cantly reduced stimulatory activity toward allogeneic T cells.
As shown in Fig 3C, CD4þ naı¨ve T lymphocytes after in-
cubation with allogeneic histamine-treated DC exhibited
slightly but significantly higher intracellular expression of
Figure1
Histamine induces the generation of monocyte-derived dendritic
cells (MoDC), that express CD14 but not CD1a. (A) Monocytes were
cultured for 6 d in the presence or absence of 10 mM histamine in
addition to interleukin (IL)-4 and granulocyte-macrophage colony-stim-
ulating factor (GM-CSF) or macrophage colony-stimulating factor.
Cytospins of control MoDC (a, d), histamine-treated cells (b, e), and
control macrophages (c, f) were labeled by the May–Gru¨nwald–Giemsa
stain (a–c) or by immunostaining for HLA-DR.  400; bar, 2 mm. (B) Mon-
ocytes were cultured for 6 d in the presence or absence of 10 mM his-
tamine in addition to IL-4 and GM-CSF and then FACS analyzed for CD1a
and CD14. (C) Cells were cultured in IL-4 and GM-CSF with different
concentrations of histamine for 6 d. (D) Cells cultured in the presence
of IL-4 and GM-CSF and 10 mM histamine were matured for 36 h with
100 ng per mL lipopolysaccharide at day 6. The data are representative
of six independent experiments with different donors. po0.05.
754 KATOH ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
IL-4 than those stimulated with control DC (8.0%  4.2% vs
4.8%  3.0%, p¼0.035, n¼ 5). The intracellular expression
of interferon-g (IFN-g) was not significantly different be-
tween them (histamine treated vs nil: 9.6%  5.4% vs
8.0%  3.0%, p¼0.47, n¼5). DC generated in the pres-
ence of histamine still induced a population of Th1 cells as
determined by a higher number of IFN-g-producing cells
when compared with IL-4 (Th2 cells).
Next, we examined their capacity to produce cytokines
and chemokines by stimulating them with 100 ng per mL of
Figure 2
Effect of histamine on the phenotypes of in vitro-generated dendritic cells (DC). (A) The expression of the surface marker is shown for control
DC (nil) and control macrophage colony-stimulating factor (M-CSF)-induced macrophage (Mph) without histamine in comparison with the cells
cultured with histamine (His) for 6 d. (B) These cells were matured with 100 ng per mL lipopolysaccharide for 36 h and FACS analyzed. The overlay
histograms represent the data from eight independent experiments with different donors. The intracytoplasmic staining for CD68 and FXIIIa was
performed by permeabilization with saponin. The values of mean rFI  SD from eight independent experiments are also demonstarated. Asterisk
indicates statistical significance between control monocyte-derived dendritic cells and histamine- or M-CSF-treated cells.
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LPS after 6 d of culturing. As reported previously (Novak
et al, 2001), GM-CSF-IL-4-induced MoDC produced less
proinflammatory cytokines and chemokines after stimula-
tion with LPS compared with M-CSF-induced macrophages
(Fig 4A,B). The ability to produce proinflammatory cyto-
kines and chemokines including IL-10, however, was sig-
nificantly elevated in histamine-treated CD1aCD14þ cells
except IL-12, which was confirmed by single-cell analysis
(Fig 4C). Endogenous production of M-CSF was not de-
tected in control MoDC and histamine-treated DC by using
ELISA (data not shown).
To investigate further as to whether histamine influences
their function, the phagocytic activity of these cells was
evaluated using fluorescein isothiocyanate (FITC)-labeled
latex beads. Although control MoDC displayed low
phagocytic activity on day 6 as reported elsewhere (Novak
et al, 2001), histamine-treated DC exhibited high phagocytic
activity compared with untreated MoDC (relative fluores-
Figure 3
Suppression of the stimulatory activity of allogeneic T cells by
dendritic cells (DC) generated in the presence of histamine. (A)
Monocytes were cultured with (open circle) or without histamine (open
square) in addition to interleukin (IL)-4 and granulocyte-macrophage
colony-stimulating factor for 6 d. These cells were washed three times
and then cocultured with purified responder allogeneic naı¨ve CD4þ T
cells for 4 d. (B) In day 6 the cells were matured with 100 ng per mL
lipopolysaccharide for 36 h and then cocultured with naı¨ve CD4þ T
cells as described above. The data are representative of five inde-
pendent experiments with different donors. Results are expressed as
the mean  SD for triplicate cultures. (C) Naı¨ve CD4þ T cells were
cocultured with control monocyte-derived dendritic cells or hitamine-
treated DC for 96 h. T cells were expanded with 50 U per mL IL-2 for 7
d, and stimulated with 5 ng per mL PMA and 500 ng per mL ionomycin
for 6 h. Brefeldin A was added during the last 2 h of culture. After
fixation and permeabilization, intracellular cytokine staining for IL-4 and
interferon-g (IFN-g) was performed. Representative dot plots of five
independent experiments with different donors are shown.
Figure4
Capacity for producing proinflammatory cytokines and chemo-
kines. (A, B) Monocytes were cultured with (open square) or without
histamine (closed square) in addition to interleukin (IL)-4 and gran-
ulocyte-macrophage colony-stimulating factor (GM-CSF) for 6 d. Al-
ternatively, monocytes were cultured in the presence of macrophage
colony-stimulating factor (M-CSF) alone for 6 days (hatched square).
After washing, the cells were stimulated with 100 ng per mL lip-
opolysaccharide for 24 h. The cytokine concentrations of the culture
supernatants were estimated by ELISA. The data are mean  SEM of
four independent experiments with different donors. (C) Alternatively,
these cells were stained with anti-CD1a fluorescein isothiocyanate
and anti-TNF-a PE after fixation and permeablization. Representative
dot blots of four independent experiments are shown. (D) Monocytes
were cultured with or without histamine for 24 h, and concentrations of
IL-10 and IL-12 p70 were estimated by ELISA. The data are mean
percentage positive  SEM of four independent experiments with
different donors.
Figure5
Effect of histamine on the phagocytic activity of dendritic cells.
Monocytes cultured with (His) and without histamine (nil) in addition to
interleukin-4 and granulocyte-macrophage colony-stimulating factor or
macrophage colony-stimulating factor (Mph) for 6 d were tested for
phagocytic capacity at 01C (black histogram) and 371C (white histo-
gram) using fluorescein isothiocyanate-labeled latex beads and flow
cytometry. Representative histograms (A) from six independent exper-
iments with different donors are shown.
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cence intensity (rFI): 20.5  3.8 and 4.5  1.0, respectively,
p¼0.0139, n¼ 6) (Fig 5).
Histamine inhibits DC differentiation through H2R To
elucidate the involvement of histamine receptor subtypes
in the inhibition of DC differentiation, experiments using
receptor subtype-selective antagonists were performed.
Histamine-induced inhibition of CD1a expression and
antigen-presenting capacity were completely blocked by
preincubation of the monocytes with cimetidine but not
with the H1R or H3R antagonists (Fig 6). In addition, the
H2R agonist inhibited CD1aþ DC generation from
monocytes.
Role of histamine-induced cytokine production by mon-
ocyte Histamine induces the release of several cytokines
from monocytes. To examine whether the inhibitory effect of
histamine on DC differentiation is mediated by endog-
enously synthesized cytokines, MoDC were generated with
IL-4 and GM-CSF in the culture supernatant of monocytes
cultured for 24 h in the presence or absence of histamine.
As shown in Fig 7, the supernatant of monocyte treated
with histamine showed a significant inhibitory effect on
CD1aþCD14 DC generation. The removal of IL-10 with
neutralizing monoclonal antibody (mAb) resulted in the res-
toration of CD1aþ DC differentiation inhibited by histamine
as seen in the phenotype and allogeneic MLR. Endogenous
production of IL-10 was 16  6 pg per mL in day 5 MoDC
and 184  32 pg per mL in histamine-treated DC (Fig 4D).
Figure 6
Histamine inhibits the generation of CD1aþ dendritic cells via H2
receptors. Monocytes were incubated with histamine receptor antag-
onists (H1R antagonist; 10 mM pyrilamine, H2R antagonist; 10 mM
cimetidine, and H3R antagonist; 100 mM thioperamine), and after 1 h,
the cells were washed three times and histamine, interleukin (IL)-4, and
granulocyte-macrophage colony-stimulating factor (GM-CSF) were
added. Alternatively, H2R agonist (10 mM dimaprit dihydrochloride)
was added with IL-4 and GM-CSF. The cells were cultured for 6 d, their
phenotypes were analyzed by flow cytometry (A), and their stimulatory
capacity for allogeneic T cells was measured by MLR (stimulator:re-
sponder¼ 1:10) (B). The data are representative of four independent
experiments with different donors.
Figure7
The culture supernatant of histamine-treated monocytes inhibited
the generation of CD1aþ dendritic cells (DC). This inhibitory effect
was blocked by the precipitation of interleukin (IL)-10 from the supe-
rnatant before its addition to cultures used to generate DC with IL-4
and granulocyte-macrophage colony-stimulating factor, but not by
precipitation of IL-1b, IL-6, IL-12, and TNF-a. (A) Dot-plot profiles for
CD1a and CD14, and (B) the percentage of CD1aþ cells. (C) The
suppressive effect of the culture supernatant of histamine-treated
monocytes in allogeneic and autologus MLR (1  104 of stimulator
cells) was impaired by IL-10 precipitation. Representative results of four
independent experiments are shown. Results are expressed as the
mean  SD of triplicate cultures.
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Pretreatment of the supernatant with anti-IL-1b, -IL-6, and
-IL-12 mAb did not induce any change in the phenotype and
function of DC. The removal of TNF-a from the supernatant
reduced CD1a expression, suggesting its enhancing role in
CD1aþ DC differentiation.
Discussion
DC comprise heterogeneous populations with different
morphologies and molecules expressed as a function of
their maturation stage. In the cutaneous tissue, Langerhans
cell (LC) is a unique DC that strongly expresses CD1a. DDC
also express varying levels of CD1a, even though CD1a
expression on DDC was consistently weaker than on LC. In
addition, LC lacks the monocyte–macrophage marker CD14
and representative DDC marker FXIIIa (Larregina et al,
2001), whereas several subpopulations of DDC can be
distinguished according to their differential expression of
CD1a, CD14, and FXIIIa. DDC migrated from skin explants
have been subdivided into three groups: CD1aþCD14,
CD1aCD14, and CD1aCD14þ (Nestle et al, 1993;
Larregina et al, 2001). According to their reports,
CD1aCD14þ DDC showed increased phagocytic activ-
ity and weak T cell-stimulatory potential. CD14þCD1a
DDC described by Nestle et al (1993), however, are positive
for intracellular FXIIIa, whereas those reported by Larregina
et al (2001) are negative for FXIIIa. This study showed that
histamine prevents the IL-4/GM-CSF-driven differentiation
of monocytes into CD1aþCD14 DC, but induced their
differentiation into CD1aCD14þFXIIIaþ cells, which ex-
hibited increased phagocytic activity and weak allo-stimula-
tory capacity. It is thus suggested that the cells generated in
the presence of histamine in this study are similar to DDC
described by Nestle et al (1993).
In this study, histamine-induced DC were stained posi-
tively for intracellular FXIIIa and CD68. Both the molecules
have been reported to be expressed in DDC, MoDC, and
macrophages, but not or only weakly on LC (Caux et al,
1996; Guironnet et al, 2001; Vakila et al, 2005). Increased
expression of molecules involved in Ag capture (mannose
receptor, CD11b) and decreased expression of costimula-
tory molecules (CD80, CD40) in histamine-treated DC may
correlate with their impaired antigen-presenting function to
T lymphocytes and a higher endocytic activity. These pheno-
typic and functional features suggest that histamine-induced
DC are in a transitional state of differentiation either toward
CD1aþCD14 DDC or macrophages, but not LC. Larregina
et al (2001) demonstrated that CD1aCD14þFXIIIa DDC
differentiated into LC when cultured with TGF-b1 alone and
that their allostimulatory capacity was enhanced when they
were cultured with IL-4, GM-CSF, and TGF-b1. It is inter-
esting to examine whether histamine-induced DC have the
potential to differentiate into LC when cultured with TGF-b1
in addition to GM-CSF and IL-4.
The fact that dust mite inhalation aggravates eruptions in
atopic dermatitis (AD) patients suggests that DDC play a
role in the pathogenesis of AD (Tupker et al, 1996). As mast
cells are present in the dermis and epidermis in the AD skin
lesions (Imayama et al, 1995), the aggregation of FceRI in-
duced by environmental allergens (e.g., dust mites and pol-
len) and subsequent degranulation of mast cells often
occur. In addition, IgE autoantibodies are frequently de-
tected in the circulation of severe AD patients (Valenta et al,
2000), suggesting that the degranulation of peripheral blood
basophils also occurs. In AD individuals, monocytes could
therefore be exposed to histamine in the skin or peripheral
circulation.
In this study, histamine prevented the generation of
CD1aþ DC from monocytes via H2R. In addition, this in-
hibitory effect was mediated by IL-10 produced endog-
enously by monocytes. This observation is in line with
previous reports that showed that (i) the addition of IL-10 at
the start of culturing with GM-CSF and IL-4 inhibits CD1aþ
MoDC generation (Buelens et al, 1997; Allavena et al, 1998),
and (ii) histamine induces monocytes and MoDC to produce
IL-10 (Elencov et al, 1998; Mazzoni et al, 2001; Gutzmer
et al, 2002; Idzko et al, 2002). The mechanism by which IL-
10 prevents CD1aþ DC generation remains unclear. IL-10
might exert a signal that causes monocytes to differentiate
into macrophages because human blood monocytes cul-
tured with IL-10 differentiate into CD16þ macrophage-like
cells (Calzada-Wack et al, 1996). Alternatively, IL-10 initiates
the signal that prevents IL-4-induced signal required for
DC differentiation. IL-10 upregulates the gene expression of
the suppressor of cytokine-signaling (SOCS)-3 (Williams
et al, 2002). SOCS-3 inhibits IL-4-dependent signal trans-
ducer and activator of transcription (Stat) 6 activation of
and subsequent gene induction (Haque et al, 2000).
Stat-mediated signals and feedback regulation by SOCS
may be involved in differentiation and maturation of DC
(Jackson et al, 2004).
Recently, several groups have shown that histamine al-
ters the repertoire of cytokines secreted by LPS-matured
DC that induces the polarization of naı¨ve CD4þ T cells to-
ward Th2 phenotypes (Caron et al, 2001; Mazzoni et al,
2001; Gutzmer et al, 2002; Idzko et al, 2002). In this study,
histamine-treated immature DC induced slightly but signif-
icantly increased intracellular expression of IL-4 in CD4þ
naı¨ve responder T cells, whereas the intracellular expression
of IFN-g was not significantly affected. Rather, DC gener-
ated in the presence of histamine still induced a population
of Th1 cells as determined by a higher number of IFN-g-
producing cells when compared with IL-4 (Th2 cells). This
may be explained by the much lower IL-10-producing ca-
pacity of histamine-treated immature DC when compared
with LPS-matured, histamine-treated DC in this and previ-
ously reported experiments (Fig 4A–D).
In this study, we discovered a new immunomodulatory
function of histamine besides its well-characterized effects
in the acute inflammatory and allergic responses; it inhibits
the differentiation of CD1aþ DC mostly through the action
of endogenously produced IL-10. Histamine induces mon-
ocytes to differentiate into CD1aCD14þ DC cells even in
the presence of IL-4 and GM-CSF, which have an enhanced
capacity to induce the production of proinflammatory
cytokines and chemokines and elevated phagocytic activ-
ity in spite of a reduced antigen-presenting capacity. This
suggests that histamine-driven DC amplify antigen-inde-
pendent inflammatory reactions and contribute to the ex-
acerbation of allergic disease. Alternatively, IL-10 produced
by histamine-treated monocytes and DC via H2R may
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induce regulatory properties of T cells because IL-10-treat-
ed DC lead to antigen-specific anergy in CD4þ T lymph-
ocytes, which is characterized by inhibited proliferation,
reduced production of IL-2, and antigen-specific suppres-
sor activity (Jonuleit et al, 2002; Steinbrink et al, 2002). The
appropriate use of HR antagonists or the use of selective
agonists may be promising therapeutic tools against allergic
disease.
Materials and Methods
Reagents FITC-labeled anti-CD1a mAb (OKT6) was obtained from
Ortho Diagnostics (Raritan, New Jersey). PE-, FITC-conjugated, or
uncojugated anti-CD1b, CD11b, CD14, CD40, CD45RO, CD68,
CD80, CD83, CD86, HLA-DR, IL-4, IL-12 (p40/p70), TNF-a, and
IFN-g were obtained from BD PharMingen (San Diego, California).
MAb against IL-10, IL-1b IL-6, and M-CSFR were purchased from
R&D Systems (Minneapolis, Minnnesota). Anti-human mannose
receptor (HyCult biotechnology, Uden, the Netherlands) and factor
XIIIa (FXIIIa, Lab Vision, Fremont, California) mAb were also pur-
chased. FITC-conjugated and unconjugated F(ab)2 goat anti-
mouse IgG Ab were acquired from Jackson Immunoresearch (West
Grove, Pennsylvania). Histamine, pyrilamine (H1R antagonist),
cimetidine (H2R antagonist), thioperamine (H3R antagonist), and
dimaprit dihydrochloride (H2R agonist) were obtained from Sigma
Chemical Co. (St Louis, Missouri). All other reagents were obtained
from Sigma Chemical Co.
Cell puriﬁcation and culture Whole blood was obtained from
non-atopic healthy volunteers under approval of our Institutional
Ethical Committee. Participants gave their written informed con-
sent, and the study was conducted according to the Declaration of
Helsinki Principles. Monocytes were isolated using Nycoprep
(Nycomed, Oslo, Norway) and the Monocyte Negative Isolation
Kit (Dinal Biotech, Oslo, Norway) according to the manufacturer’s
instructions. The monocytes were cultured with 100 ng per mL
GM-CSF and IL-4, or M-CSF (R&D Systems) in low-endotoxin
RPMI 1640 (Biochrom KG, Berlin, Germany) supplemented with
10% FCS, 100 mM L-glutamine, and 1% antibiotic–antimycotic (all
from Gibco BRL, Gaithersburg, Maryland) for 6 d at 371C and 5%
CO2 as described previously (Novak et al, 2001). All plastic ware
and culture reagents used were tested for the presence of endo-
toxin with the Limulus amebocytes lysate E-Toxate multiple test.
Endotoxin levels were always o10 pg per mL.
Proliferation assays Allogeneic MLR were conducted in 96-well
round-bottom microtiter plates by adding different amounts of ir-
radiated (3000 rad) DC on day 6 to 1  105 allogeneic and auto-
logus naı¨ve CD4þ T cells, which were obtained with a CD4þ
isolation kit (Dynal, Oslo, Norway), and subsequent negative
selection in combination with anti-CD45RO mAb plus goat
anti-mouse IgG Ab-conjugated immunomagnetic beads (Dynal).
After 4 d at 371C, cell proliferation was assessed by the uptake of
[3H]thymidine (1.25 mCi per well present for 16 h; Amersham,
Little Chalfont, UK).
Flow cytometry Surface and intracellular molecule labeling was
performed as previously reported (Novak et al, 2001). The rFI was
assessed as follows: rFI¼ (mean fluorescence intensity (MFI) (sur-
face molecule)–MFI (control)/MFI (control). Phagocytic activity was
tested by using fluorescence-labeled latex beads (Polysciences,
Wallington, Pennsylvania). Briefly, cultured cells in the absence or
presence of histamine on day 5 were incubated with the beads for
3 h at 37 or 01C. After washing three times, the cells were fixed with
4% paraformaldehyde, and then the percentage of cells that per-
formed phagocytosis was analyzed by flow cytometry.
Generation of culture supernatant from monocytes The culture
supernatant of monocytes was harvested, and the cytokine
present in it was blocked as described previously (Katoh et al,
2000). Briefly, monocytes were cultured for 24 h with or without 10
mM histamine. The supernatants were collected and centrifuged
twice at 41C, followed by immediate storage at 801C. In blocking
experiments, 500 mL of the supernatant was first treated with anti-
cytokine neutralizing mAb (10 mg per mL) for 30 min at 371C. Then,
20 mL of protein G-Sepharose (Amersham Pharmacia Biotech,
Uppsala, Sweden) was added at 41C for 2 h to precipitate bound
cytokines. After centrifugation, the supernatant was collected, and
then monocytes were cultured in the supernatants. Cytokine con-
centrations in the supernatants were examined by using commer-
cially available ELISA kits (R&D Systems).
Statistical analysis Data are expressed as the means  SD. Sta-
tistical differences were determined using paired and unpaired
t-tests, and a p value of less than 0.05 was considered to be
statistically significant.
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